Follow-up
•
Median follow-up for all patients 13.4 years
–
Cases (BRCA1/2 mutation carriers): 13.9 years
[3-19.2]
Familial cases (Non carriers)
13.4 years [2.3-22.5]
Controls:
13 years
[2.7-24.8]